Ilyang Pharm (Korea) Today
| 007570 Stock | 11,040 130.00 1.19% |
PerformanceWeak
| Odds Of DistressLow
|
Ilyang Pharm is trading at 11040.00 as of the 20th of March 2025, a 1.19 percent up since the beginning of the trading day. The stock's open price was 10910.0. Ilyang Pharm has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Moving against Ilyang Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Ilyang Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ilyang Pharm's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ilyang Pharm or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Pres CEO | DongYeon Kim |
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Ilyang Pharm (007570) is traded on Korea Stock Exchange in Korea and employs 675 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 345.28 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ilyang Pharm's market, we take the total number of its shares issued and multiply it by Ilyang Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ilyang Pharm operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 18.09 M outstanding shares.
Ilyang Pharm generates positive cash flow from operations, but has no cash available
Check Ilyang Pharm Probability Of Bankruptcy
Ownership AllocationIlyang Pharm has a total of 18.09 Million outstanding shares. Ilyang Pharm secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ilyang Ownership Details
Ilyang Pharm Risk Profiles
Although Ilyang Pharm's alpha and beta are two of the key measurements used to evaluate Ilyang Pharm's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.54 | |||
| Semi Deviation | 1.81 | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.89 |
Ilyang Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ilyang Pharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Other Information on Investing in Ilyang Stock
Ilyang Pharm financial ratios help investors to determine whether Ilyang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ilyang with respect to the benefits of owning Ilyang Pharm security.